Almac Diagnostics Expands Biomarker Biz With Illumina Tech
Almac Diagnostics has launched a new cancer tumour profiling services that will use Illumina’s next-generation sequencing (NGS) TruSight Tumor panel.
Almac Diagnostics has launched a new cancer tumour profiling services that will use Illumina’s next-generation sequencing (NGS) TruSight Tumor panel.
Synthesis Med Chem has opened a UK facility in an effort to win more pharma and biotech customers in Europe.
UPDATE
Sanofi has inked a multimillion dollar licensing deal with Unilife for its prefilled syringes that will simplify its Lovenox and Clexane supply chains.
Knowing about manufacturing innovations as soon as possible is more important for BioPharmas than for their small molecule counterparts according to an MIT Professor interviewed by our new sister site BioPharma-Reporter.com
Hospira says efforts to ramp up supply from its troubled Rocky Mount plant are dictated by remediation levels.
Clinical trial sponsors are now asking CROs to do more as an industry and as the top contracting companies build teams of scientists and physicians as varied as some hospital chains, sponsors’ reliance on outsourcing may have yet to peak.